Prostate Cancer Clinical Trial
Official title:
Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal mHealth Intervention
This study evaluates a smart phone based mobile application designed for patients with Renal
Cell and Prostate Cancer taking oral anti-cancer medications. (OAMs) All participants will be
patients at the Dana Farber Cancer Institute in Boston, Massachusetts. Half of the
participants will use the mobile application for a 3 month period along with their usual
care. Half of the participants will just receive usual care.
The investigators hope to show that cancer patients taking OAMs who use the mobile
application will be better connected to their care team and will develop increased competency
for self-care which will primarily increase medication adherence.
The widespread and increasing use of oral anti-cancer medications (OAMs) has been ushered in
by a rapidly increasing understanding of cancer pathophysiology. Furthermore, OAMs' popular
ease of administration and potential cost savings has highlighted their central position in
the healthcare system as a whole. Importantly, these facts have heightened appreciation of
the unique challenges associated with OAMs use, especially in relation to prescribing,
dispensing, reimbursement, education, adherence, and comprehensive quality and safety
assurance. In this regard, the investigators goal is to improve medication adherence and
clinical outcomes for cancer patients using OAMs through a mobile-enabled, multi-modal
self-management and educational intervention .
The intervention seeks to enable patients' self-efficacy to adhere to their medications
through directed education and coaching, anticipation of symptoms and associated adverse
events, and closer monitoring with accurate assessment of self-reported outcomes. This
innovative approach necessarily includes personalizing feedback and management based on
patients' own treatment regimen, baseline knowledge and elucidated barriers to adherence, and
holds great promise in improving overall adherence, safety, and clinical outcomes in these
patients.
The investigators hypothesize that cancer patients on OAMs who use a mobile-based,
multi-modal health self-management (M health) intervention designed for extensive patient
education and symptom management will be better connected to their care team and will develop
increased competency for self-care which will primarily increase medication adherence and
improve secondary outcomes measured in this study compared to cancer patients on OAMs who do
not use the mobile-based intervention.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |